Metabolomics of human brain aging and age-related neurodegenerative diseases
about
Urinary Biomarkers of Brain DiseasesAltered lipid metabolism in the aging kidney identified by three layered omic analysisToward defining the anatomo-proteomic puzzle of the human brain: An integrative analysis.Changes in Brain Metallome/Metabolome Pattern due to a Single i.v. Injection of Manganese in Rats.Plasma metabolomic profile and potential biomarkers for missed abortion.High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue.Three plasma metabolite signatures for diagnosing high altitude pulmonary edema.Quantitative in vivo neurochemical profiling in humans: where are we now?Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorderMetabolomic Analysis in Brain Research: Opportunities and ChallengesSpecific Metabolomics Adaptations Define a Differential Regional Vulnerability in the Adult Human Cerebral Cortex.Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients.Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism.A plasma metabolomic signature discloses human breast cancer.Future perspectives: Moving towards NCL treatments.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Non-enzymatic molecular damage as a prototypic driver of aging.HDAC inhibitor-dependent transcriptome and memory reinstatement in cognitive decline models.Biomarker Research in Parkinson's Disease Using Metabolite Profiling.Late-onset Alzheimer's disease is associated with inherent changes in bioenergetics profiles.Retrospection on the Role of Soluble Guanylate Cyclase in Parkinson's Disease.Do age and sex impact on the absolute cell numbers of human brain regions?Human Aging Is a Metabolome-related Matter of Gender.Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study.Sisyphus in Neverland.Single Cell Neurometabolomics.Toll Like Receptor 4 Affects the Cerebral Biochemical Changes Induced by MPTP Treatment.Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia.A study of microRNAs from dried blood spots in newborns after perinatal asphyxia: a simple and feasible biosampling method.UPLC‑QTOFMS‑based metabolomic analysis of the serum of hypoxic preconditioning mice.Growth of Malignant Non-CNS Tumors Alters Brain Metabolome.Tetrahydroxystilbene glucoside ameliorates memory and movement functions, protects synapses and inhibits α-synuclein aggregation in hippocampus and striatum in aged mice.A Potent Multi-functional Neuroprotective Derivative of Tetramethylpyrazine.A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.Dynamic metabolic patterns tracking neurodegeneration and gliosis following 26S proteasome dysfunction in mouse forebrain neurons.Metabolic abnormalities of gastrointestinal mucosa in celiac disease: An in vitro proton nuclear magnetic resonance spectroscopy study.Tocotrienol-Rich Fraction of Palm Oil Improves Behavioral Impairments and Regulates Metabolic Pathways in AβPP/PS1 Mice.Identification of candidate biomarkers of brain damage in a mouse model of closed head injury: a metabolomic pilot studyAlzheimer's Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk MarkersThe Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases
P2860
Q26769944-75605DAA-EBB8-4BB1-B850-6E1415816F57Q28392301-C0BD2F7E-D50D-4139-AFD3-09421BA90C64Q33359479-F0ABDA4F-649E-463B-8964-B8EE4D62F041Q35780303-CFB4F9CA-7BF1-4AD0-8FAF-75FFE8B1AB2EQ36031160-92840A7B-77AA-4A7F-943A-7F3FF6A3009DQ36077253-853B50D3-6079-4583-B290-538D7A2167D4Q36150268-54A58F01-C6F5-4300-861A-6D2063218126Q36177915-D0AC6319-E4A4-4DCB-8A69-86C835E4C031Q36869854-D2D51952-26A3-44B2-A95E-E845DB90ADACQ36930380-F52DE5C1-BBCA-4DC8-9F33-76DFAD5B7966Q37483166-A8CD5439-50E9-40A7-A1E8-413D7A22DCBDQ37510154-FC5DF4B7-6C56-4F12-947E-FD1E786F65B0Q37588464-618F37E8-894A-4CC9-BC8D-41903BDD662AQ37746050-FEA7A6CF-D8E3-4084-A1C6-A766CCAB7089Q38413183-99D85967-62AD-44FA-9C88-FA02CA1BEEDAQ38979999-59BA5691-2235-4374-928D-1411B7BC7EC6Q39164374-E7E308C1-D4D1-4FFB-AEB1-709E08A2A57EQ41608936-830C1F7B-0BD6-4C39-A0D1-74522E7C7889Q41666702-16D342BE-2293-429F-B49C-8BBC0DBC6739Q42630551-47CCE9AC-9297-4F79-ACC5-B3A4587E61C4Q42699608-F261EB05-9E7C-48D6-829C-BAE21E041BA1Q46485436-1433B4B5-5F46-4D1A-A786-2BEB64AA9DDAQ46722997-093B9D6A-A9CC-4086-8472-6398536AED6EQ47595258-61976C50-8FBA-45B8-9D17-30AE8DB0BA9AQ47607995-8BB9788E-E22C-48C9-B058-276DE9FA1CA2Q48032444-DC30C51D-A9DC-4F70-A6BB-636B07495F9EQ48347050-4078FDFD-BF48-4EC0-A7C1-0BC5FEED1D60Q48360194-97E87F25-F196-49FA-90B8-31ABDEF844B1Q49067403-0FBC5C88-57D0-4301-B754-7310ADA82D0BQ50122533-0A3EB0AD-9E8A-4456-8062-2EAC9CAA18D9Q50420431-1A857716-9A8C-4C7D-BD8B-7D653224874EQ50558906-0D427779-BEA0-48EA-83C8-CD1B90832B18Q50734809-98598440-A6AE-493E-B3D7-339AAAD5A9CBQ52721984-ADD7B54C-5AF0-4882-A86E-364194EE54A6Q52725603-0E2B044D-3F41-419F-9F5A-AC95D67D7B59Q53547890-9A7DD642-9FC3-47A8-A8D5-FB317C3BF396Q55266361-CB978F6A-A156-4405-AB6C-4495E42F9FC7Q57014206-9EC140CD-5B13-45FC-ACFA-7DDDCB3D24F5Q58586046-376DDC30-580F-4CE1-B3F3-7F1450B49A5FQ58787876-3567F2F6-EE78-4288-B0DE-BE79F382D732
P2860
Metabolomics of human brain aging and age-related neurodegenerative diseases
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metabolomics of human brain aging and age-related neurodegenerative diseases
@ast
Metabolomics of human brain aging and age-related neurodegenerative diseases
@en
Metabolomics of human brain aging and age-related neurodegenerative diseases
@nl
type
label
Metabolomics of human brain aging and age-related neurodegenerative diseases
@ast
Metabolomics of human brain aging and age-related neurodegenerative diseases
@en
Metabolomics of human brain aging and age-related neurodegenerative diseases
@nl
prefLabel
Metabolomics of human brain aging and age-related neurodegenerative diseases
@ast
Metabolomics of human brain aging and age-related neurodegenerative diseases
@en
Metabolomics of human brain aging and age-related neurodegenerative diseases
@nl
P2860
P50
P3181
P1476
Metabolomics of human brain aging and age-related neurodegenerative diseases
@en
P2093
Isidre Ferrer
P2860
P304
P3181
P356
10.1097/NEN.0000000000000091
P407
P577
2014-07-01T00:00:00Z